Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Early Routine vs. Selective Human Milk Fortification in Extremely Preterm Infants — Stella

Home/Poor Growth in Extremely Preterm Infants/

View on ClinicalTrials.gov

Recruiting

Back to Poor Growth in Extremely Preterm Infants trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Crouse Hospital, Syracuse, New York

Key details

Sponsor

Crouse Hospital

Enrollment target

~200 participants

Started

February 2020

Primary completion

January 2024

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

0 Days – 6 Days

Last updated February 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.